Nov 6 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2020 Sep 30, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 247 mln 230 mln 549 mln
(+7.4 pct) (-40.0 pct) (-4.8 pct)
Operating loss 177 mln loss 209 mln loss 308 mln
Recurring loss 227 mln loss 252 mln loss 410 mln
Net loss 230 mln loss 254 mln loss 430 mln
EPS loss 24.75 yen loss 29.18 yen loss 46.16 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T